Financials Alexandria New Medical Center
Equities
AMES
EGS72081C010
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
64.52 EGP | 0.00% | 0.00% | +9.73% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 341 | 263.5 | 580 | 849.3 | 1,145 | 915.7 |
Enterprise Value (EV) 1 | 350.7 | 275.7 | 558.7 | 801.4 | 1,097 | 882 |
P/E ratio | 14.5 x | 11.3 x | 30.3 x | 32.1 x | 154 x | 154 x |
Yield | - | - | - | 1.47% | - | - |
Capitalization / Revenue | 1.86 x | 1.23 x | 2.57 x | 3.13 x | 4.38 x | 3.3 x |
EV / Revenue | 1.91 x | 1.29 x | 2.48 x | 2.96 x | 4.2 x | 3.18 x |
EV / EBITDA | 8.32 x | 5.62 x | 11.5 x | 13.9 x | 39.3 x | 44.8 x |
EV / FCF | -20.2 x | -115 x | 17.1 x | 20.4 x | 53.3 x | -60.5 x |
FCF Yield | -4.95% | -0.87% | 5.85% | 4.91% | 1.88% | -1.65% |
Price to Book | 1.82 x | 1.28 x | 2.57 x | 3.4 x | 4.91 x | 4.79 x |
Nbr of stocks (in thousands) | 15,573 | 15,573 | 15,573 | 15,573 | 15,573 | 15,573 |
Reference price 2 | 21.90 | 16.92 | 37.24 | 54.54 | 73.50 | 58.80 |
Announcement Date | 2/10/19 | 2/2/20 | 3/7/21 | 3/24/22 | 2/28/23 | 3/2/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 183.7 | 213.7 | 225.4 | 271.1 | 261 | 277.7 |
EBITDA 1 | 42.16 | 49.01 | 48.7 | 57.7 | 27.93 | 19.68 |
EBIT 1 | 33.01 | 37.9 | 36.75 | 45.07 | 17.7 | 9.541 |
Operating Margin | 17.97% | 17.73% | 16.3% | 16.62% | 6.78% | 3.44% |
Earnings before Tax (EBT) 1 | 32.17 | 32.31 | 30.44 | 43.31 | 21.87 | 14.04 |
Net income 1 | 24.61 | 24.71 | 20.85 | 26.45 | 7.446 | 5.932 |
Net margin | 13.4% | 11.56% | 9.25% | 9.76% | 2.85% | 2.14% |
EPS 2 | 1.506 | 1.502 | 1.229 | 1.699 | 0.4781 | 0.3809 |
Free Cash Flow 1 | -17.37 | -2.39 | 32.7 | 39.33 | 20.61 | -14.59 |
FCF margin | -9.45% | -1.12% | 14.51% | 14.51% | 7.9% | -5.25% |
FCF Conversion (EBITDA) | - | - | 67.14% | 68.17% | 73.81% | - |
FCF Conversion (Net income) | - | - | 156.81% | 148.71% | 276.8% | - |
Dividend per Share | - | - | - | 0.8000 | - | - |
Announcement Date | 2/10/19 | 2/2/20 | 3/7/21 | 3/24/22 | 2/28/23 | 3/2/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 9.63 | 12.1 | - | - | - | - |
Net Cash position 1 | - | - | 21.3 | 47.9 | 47.1 | 33.6 |
Leverage (Debt/EBITDA) | 0.2285 x | 0.2473 x | - | - | - | - |
Free Cash Flow 1 | -17.4 | -2.39 | 32.7 | 39.3 | 20.6 | -14.6 |
ROE (net income / shareholders' equity) | 14% | 12.6% | 9.68% | 11.1% | 3.14% | 3.15% |
ROA (Net income/ Total Assets) | 7.18% | 7.41% | 7.06% | 8.43% | 3.37% | 2.05% |
Assets 1 | 342.8 | 333.3 | 295.2 | 313.7 | 221.2 | 289.8 |
Book Value Per Share 2 | 12.00 | 13.20 | 14.50 | 16.00 | 15.00 | 12.30 |
Cash Flow per Share 2 | 3.180 | 3.120 | 2.980 | 4.250 | 3.440 | 2.670 |
Capex 1 | 35.8 | 21.5 | 6.77 | 13.8 | 6.98 | 14.1 |
Capex / Sales | 19.51% | 10.08% | 3% | 5.08% | 2.68% | 5.07% |
Announcement Date | 2/10/19 | 2/2/20 | 3/7/21 | 3/24/22 | 2/28/23 | 3/2/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+9.73% | 20.98M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+9.72% | 10.79B | |
+23.61% | 8.26B | |
-2.19% | 7.68B | |
+20.75% | 7.2B | |
+4.49% | 6.67B | |
+50.89% | 4.66B |
- Stock Market
- Equities
- AMES Stock
- Financials Alexandria New Medical Center